New Results
Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19
Meehyun Ko, So Young Chang, Soo Young Byun, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, David Shum, Ji-Young Min, Marc P. Windisch
doi: https://doi.org/10.1101/2020.02.25.965582
Meehyun Ko
aRespiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
So Young Chang
aRespiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
Soo Young Byun
bScreening Discovery Platform, Translation Research Division, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
Inhee Choi
cMedicinal Chemistry, Medicinal Chemistry & Business Development Group, Translational Research Department, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
Anne-Laure Pham Hung d’Alexandry d’Orengiani
aRespiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
David Shum
bScreening Discovery Platform, Translation Research Division, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
Ji-Young Min
aRespiratory Virus Laboratory, Emerging Virus Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
Marc P. Windisch
dApplied Molecular Virology Laboratory, Unmet Medical Needs Group, Discovery Biology Department, Institut Pasteur Korea, Seongnam, Gyeonggi, Republic of Korea
eDivision of Bio-Medical Science and Technology, University of Science and Technology, Yuseong-gu, Daejeon, Republic of Korea
Article usage
Posted March 02, 2020.
Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19
Meehyun Ko, So Young Chang, Soo Young Byun, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, David Shum, Ji-Young Min, Marc P. Windisch
bioRxiv 2020.02.25.965582; doi: https://doi.org/10.1101/2020.02.25.965582
Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19
Meehyun Ko, So Young Chang, Soo Young Byun, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, David Shum, Ji-Young Min, Marc P. Windisch
bioRxiv 2020.02.25.965582; doi: https://doi.org/10.1101/2020.02.25.965582
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)